Stock 300601 SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shenzhen Kangtai Biological Products Co., Ltd.

Equities

300601

CNE100002Q33

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
20.75 CNY +7.01% Intraday chart for Shenzhen Kangtai Biological Products Co., Ltd. +4.06% -23.57%
04-26 Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kangtai Biological Forecasts Swing to Profit in 2023
MT
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023
CI
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend
CI
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India
MT
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023
CI
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine
MT
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
CI
Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback announced on October 12, 2022 has closed with 3,581,600 shares, representing 0.32% for CNY 120.97 million.
CI
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand
RE
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
CI
Shares in Chinese Pharma Companies Decline Amid Drop in Vaccination Rates
MT
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.
CI
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.
CI
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300601 Stock
  4. News Shenzhen Kangtai Biological Products Co., Ltd.